Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3

Research Article

Amelioration of CCl4-Induced Hepatotoxicity in Rabbits by Lepidium sativum Seeds

Table 3

Liver profile of untreated, LSS administered, CCl4 treated, and LSS protected rabbits. Effect of LSS on serum marker enzymes ALT, AST, GGT, ALP, T.BILI, TP, ALB, TG, and CHOL in rabbits treated with CCL4 induced hepatotoxicity as indicated in the figure. All data were expressed as mean ± SEM. Values were statistically tested using the Student t-test and significant differences at p < 0.05 and p < 0.01 as indicated by ()& ()compared to normal control, by (#) & (##) compared to CCL4 after 5 weeks, and by (+) & (++) compared to CCL4 after 10 weeks, respectively.

GroupALT (U/L)AST (U/L)G GT (U/L)ALP (U/L)T.BILI (mg/dl) TP (g/dl)ALB (g/dl)CHOL (mg/dl)TG (mg/dl)

Control38.01 ± 4.6827.25 ± 1.927.02 ± 1.2422.02 ± 1.620.28 ± 0.036.50 ± 0.313.55 ± 0.1716.32 ± 5.0642.03 ± 4.69
LS (200mg/kg bw)31.48 ± 6.7829.41 ± 3.318.48 ± 1.2057.02 ± 2.290.43 ± 0.036.40 ± 0.253.24 ± 0.1332.17 ± 2.8752.74 ± 2.79
LS (400mg/kg bw)16.44 ± 1.4620.76 ± 3.436.29 ± 2.2953.08 ± 1.610.46 ± 0.035.86 ± 0.473.44 ± 0.1031.61 ± 3.0526.10 ± 3.04
CCl4 (5 wk.)56.76 ± 5.4662.30 ± 3.9128.72 ± 2.76114.83 ± 2.730.67 ± 0.044.14 ± 0.142.48 ± 0.2589.21 ± 7.62147.74 ± 7.44
% of Change49128310421139- 36- 3072250
CCl4 (10 wk.)67.00 ± 4.7670.69 ± 6.4539.78 ± 2.26126.38 ± 3.710.60 ± 0.044.45 ± 0.12.61 ± 0.2299.96 ± 6.16163.79 ± 8.9
% of Change76159468474114- 31- 265.122.9
CCl4 + LS (200mg/kg bw) 5 wk30.62 ± 2.19##24.90 ± 3.02##19.62 ± 1.95 ##59.60 ± 2.37##0.33 ± 0.03##6.49 ± 0.20##3.39 ± 0.12##51.35 ± 5.47##89.78 ± 6.11##
% of Change- 46- 60- 31- 48- 505737- 42- 39
CCl4 + LS (400mg/kg bw) 5 wk24.23 ± 2.91++20.27 ± 3.09++14.64 ± 1.73++61.46 ± 4.16++0.44 ± 0.03++5.76 ± 0.62++3.26 ± 0.20++63.06 ± 5.24++105.39 ± 5.62++
% of Change- 57- 67- 49- 46- 343931- 29- 28
CCl4 + LS (200mg/kg bw) 10 wk38.04 ± 3.71##23.90 ± 2.64##15.81 ± 1.42##52.59 ± 2.57##0.38 ± 0.04##6.36 ± 0.38##3.38 ± 0.09##52.36 ± 4.47##98.70 ± 3.44##
% of Change- 43- 66- 60- 58- 364329- 47- 39
CCl4 + LS (400mg/kg bw)10 wk40.18 ± 2.92++25.16 ± 5.08++22.92 ± 2.54++79.54 ± 4.84++0.48 ± 0.03 ++6.35 ± 0.38++3.34 ± 0.14++65.57 ± 7.98++105.13 ± 6.66++
% of Change- 40- 64- 42- 37- 204227- 34- 36

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.